Zeitschrift für Lebensmittel-Untersuchung und -Forschung 1995-10-01

Reaction of 3-deoxypentosulose with N-methyl- and N,N-dimethylguanidine as model reagents for protein-bound arginine and for creatine.

R Sopio, M Lederer

Index: Z. Lebensm. Unters. Forsch. 201(4) , 381-6, (1995)

Full Text: HTML

Abstract

Deoxyosones are established key-intermediates in Maillard processes. Due to their dicarbonyl structure, they undergo condensation to form heterocyclic compounds with guanidine derivatives. In biological systems, guanidino functions are present in protein-bound arginine moieties as well as in creatine. The reactivity of such structures towards 3-deoxypentosulose is investigated with N-methyl- and N,N-dimethylguanidine as model substrates. Two diastereoisomers each are isolated from both reactions; they have been characterized unequivocally, respectively, as 4-(2,3-dihydroxypropyl)-2-N-methylamino-2-imidazoline-5-one and 4-hydroxy-5-(2,3-dihydroxypropyl)-2-(N,N-dimethylamino)-5H-imidazole. In aqueous medium as well as in the crystalline state, both diastereoisomer pairs exist in different tautomeric forms.


Related Compounds

Related Articles:

Engineering of indole-based tethered biheterocyclic alkaloid meridianin into β-carboline-derived tetracyclic polyheterocycles via amino functionalization/6-endo cationic π-cyclization.

2012-01-01

[Beilstein J. Org. Chem. 8 , 1901-8, (2012)]

Interactions of guanidine and a related compound with potassium channels in frog myelinated nerve fibre.

1993-01-01

[Receptors Channels 1(3) , 181-91, (1993)]

Effects of 1,1-dimethylguanidine administration on blood pressure, heart rate and renal sympathetic nerve activity in normotensive and spontaneously hypertensive rats.

1997-01-01

[Acta Physiol. Scand. 159(1) , 1-6, (1997)]

Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine.

1996-01-15

[Arch. Biochem. Biophys. 325(2) , 227-34, (1996)]

Structure-activity relationship between guanidine alkyl derivatives and norepinephrine release: site(s) and mechanism(s) of action.

1984-09-01

[J. Pharmacol. Exp. Ther. 230(3) , 710-7, (1984)]

More Articles...